Dr. Peter Gasser has been interested in researching the therapeutic benefits of LSD since he took his first dose 25 years ago. Having personally met and studied the chemical substance with Albert Hoffman, the inventor of acid himself, there’s likely no man in the world more knowledgeable than he is on the subject.
In 2007 the Swiss Ministry of Health approved a study investigating the effects of acid on patients suffering from cancer and other terminal illnesses, which went on to become the first controlled trial of the drug in the 21st century.
At the forefront of research into the medical benefits of LSD is Dr. Peter Gasser, a Swiss physician with an exclusive license to administer mind-altering substances.
The results of the study were published in 2014 under the name ‘LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects.’
“Several [subjects] died within a year after the trial – but not before having a mental adventure that appeared to have eased the existential gloom of their last days,” wrote the New York Times.
These days, there is an ongoing conversation about the potentially beneficial use of psychoactive and brain-altering chemicals as a form of therapy, most notably around marijuana and recently, MDMA.
You can read a full interview Gasser conducted with Vice last year right here if you want to know more about his life, research or the modern dialogues around LSD.
